Ardent Health recharacterizes Martin Bonick's exit as termination for cause
Ardent Health reclassified its former CEO's departure as termination for cause, cancelling remaining severance and unvested PRSUs.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
Ardent Health has reclassified the June 2 departure of Martin J. Bonick as a termination for cause. TradingView reports this based on documents filed with the SEC. The board made its determination on October 19, 2026, and the separation date remains June 2, 2026.
According to the filing, the board concluded that Bonick, who served as president, chief executive officer and a board member, did not fully disclose compensation from third parties that company policies required him to report. As a result, his remaining separation benefits are discontinued, including approximately $4.5 million in unpaid cash severance, and his unvested PRSUs are to be cancelled or forfeited.
why it matters
For the market, this is a company-specific governance event. The roughly $4.5 million at stake is small relative to Ardent Health's size, but decisions about executive compensation disclosure and governance are closely watched by shareholders and investors.
tags
instruments
sources
- Ardent Health reclassifies Martin J. Bonick's departure as termination for cause — TradingView, 23 October 2026 at 20:53 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗